LIGHT: The International Retinal Laser Society
Second Annual Meeting
The Palmer House Hotel
7:30am – 5:30pm
Chicago, IL October 13, 2016
Society membership is required for attendance and participation. Your Society dues and meeting registration fee will be one-in-the-same.
Bert M. Glaser, MD
Chairman of the Board, LIGHT: The International Retinal Laser Society
Moderator – Jeffrey K Luttrull, MD Ventura, California
8:05 577nm micropulse laser as adjunctive therapy to intravitreal bevacizumab for diabetic macular edema. Verena Juncal, Camilla Xavier, Renato Passos, Jose Belucio-Neto, Luiz Roisman, Caio Regatieri, and Mauricio Maia. UNIFE Sao Paolo, Brazil.
8:25 Panretinal photocoagulation with 577nm multispot vs. 532 single-spot laser for diabetic retinopathy: a clinical trial. Renato Passos, Jose Belucio-Neto, Edoardo Novoais, Camila Xavier, and Mauricio Maia. UNIFE Sao Paolo, Brazil.
8:45 Micropulse threshold photocoagulation for the treatment of microaneurysms adjacent to the fovea. Tomoki Kurihara, Satoko Araki, Keiji Inagaki, Masafumi Hamada, and Kishiko Ohkoshi. St. Luke’s International Hospital, Tokyo, Japan.
9:05 Telemedicine-based navigated macular photocoagulation for diabetic macular edema. Igor Kozak, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
Photonic Biomodulation / Light Therapy
Moderator – David Ramsey, MD, PhD, Burlington, Massachusetts
9:25 A pilot investigation of a device to prevent dark adaptation during the hours of sleep as a complimentary therapy for clinically significant diabetic macular edema. David Ramsey, Lahey Hospital, Burlington, Massachusetts; Geoffrey Arden, Univ. College, London; Chris Hogg, Moorfields Eye Hosp., London; Gregory Blaha, Fina Barouch, Jeffrey Chang, David Lazar, and Jeffrey Marx, Lahey Hosp.; Samuel Poulin Tufts Univ., Boston; and Lauren Lamonica, Yale Univ., New Haven, Connecticut..
9:45 Photobiomodulation (PBM). What it is and what it isn’t. Robert Dotson, LumiThera, Inc.
10:05 Low-energy light treatment of wet AMD after completion of standard anti-VEGF therapy. Andriy Sergienko, National Postgrad. Med. Acad. Kiev, Ukraine; Natalia Dzuba, Kiev City Hospital #9, Ukraine; and Oleksandr Pekaryk Vision Aid, Inc, Winnipeg, Canada.
Moderator – Daniel Palanker, PhD Stanford, Calfornia
10:40 Selective retina therapy (SRT) with automatic real-time feedback controlled dosimetry (RFD) for the treatment of chronic serous chorioretinopathy with multiple foveal leaks. Young Jung Roh, Catholic Univ. of Korea; and Ralf Brinkmann, Medical Laser Center, Lubeck, Germany.
11:00 The effect of photocoagulation using PASCAL Streamline yellow on single-layer retinal pigment epithelial cells. Masafumi Hamada, Kishiko Ohkoshi, and John Shing. St. Luke’s International Hospital, Tokyo, Japan.
11:20 Tissue response to micropulse modulation in retinal laser therapy. Daniel Palanker, Jenny Wang, Quan Yi, and Roopa Dalal. Stanford University, Stanford, California.
11:40 – 11:45 Aperitif’: Hunter’s Syndrome: How a surgeon’s experience of transfoveal laser treatment of his 20/15 eye informs laser dosimetry. Jeffrey K Luttrull, Ventura, California
Moderator – Prof. Alfonso Giovannini, MD, PhD Bologna, Italy
1: 20 Study of the vitreous proteome to discover biomarkers that predict laser response. Bert M Glaser, Matthew Katz, The National Retina Institute, Towson, Maryland; and Natsumi Takahashi, Ocular Proteomics.
1:40 Response of vitreous biomarkers to retinal laser. Matthew Katz, Bert M Glaser, The National Retina Institute, Towson, Maryland; and Natsumi Takahashi, Ocular Proteomics.
2:00 Subthreshold micropulse retinal phototherapy: the role of local and systemic mediators. David Kent, The Vision Clinic, Kilkenny Ireland; Sergio Cabellaro, Univ. of Florida; and Maria Grant, Indianapolis University.
Moderator – Prof. Edoardo Midena, MD, PhD Padova, Italy
2:40 Subthreshold laser treatment for serous retinal detachment in dome-shaped macula associated with pathologic myopia. Maurizio Battaglia Parodi, Univ Vita-Salute Hospital, Milan, Italy; Pierluigi Iacono, Fondazaione Bietter, IRCSS, Rome, Italy; and Francesco Bandelloi, Univ Vita-Salute Hospital, Milan, Italy.
3:00 Subthreshold diode micropulse laser (SDM) as retinal protective therapy (RPT) for retinitis pigmentosa and other non-age related retinopathies. Jeffrey K Luttrull, Ventura, California.
3:20 Resolved: Titration improves subthreshold laser treatment safety. Pro: Daniel Palanker, Stanford University, Stanford, California; Con: Jeffrey K Luttrull, Ventura, California
Age-Related Macular Degeneration
Moderator – Matthew Katz, MD Towson, Maryland
3:40 Visual function evaluation of eyes following contiguous pan-macular micropulse laser treatment for atrophic age-related macular degeneration. Stephen H. Sinclair, Media, Pennsylvania; Jeffrey K Luttrull, Ventura, California; Kevin Marsh, Drexel Univ School of Medicine, Philadelphia; and Walter Gutstein, Univ. of Vienna, Austria.
4:00 Reduced risk of choroidal neovascularization in patients with dry age-related macular degeneration following subthreshold diode micropulse laser (SDM) as retinal protective therapy (RPT). Solly Elmann, Bert Glaser, The National Retina Institute, Towson, Maryland; Giorgio Dorin, Ojai Retinal Technologies LLC, Ojai, California; and Jeffrey K Luttrull, Ventura, California.
4:20 LIGHT Clinical Trial
Stephen H Sinclair, MD
Cocktails / BOD meeting
4:30 – 5:30Register / Sign Up!
This content is for members only. You must log in to view this content.
NOTES from 2015
The first annual meeting of LIGHT: The International Retinal Laser Society was a full-day meeting held Thursday, November 12, 2015 at Harrah’s Las Vegas to precede the AAO and AAO subspecialty days.
LIGHT: The International Retinal Laser Society
First Annual Meeting
*See “Archives” for presentation abstracts
Harrah’s Las Vegas, November 12, 2015
7:00-8:00 Breakfast and Sponsor Exhibits (Tahoe Room)
8:00 Welcome (Reno Room)
Free Papers I Moderator: Edoardo Midena (Padova, Italy)
8:05- 8:25 Micropulse contiguous grid laser for diffuse diabetic macular edema resistant to drug treatment. Stephen Sinclair (Philadelphia, USA)
8:25-8:40 Navigated focal non-destructive laser for diabetic macular edema. Matthew Katz, Alexandre Gauthier, Bert Glaser (Baltimore, USA)
9:00-9:20 Combination therapy with subthreshold diode laser micropulse photocoagulation and intravitreal anti-vascular endothelial growth factor injections for diabetic macular edema. Lawrence Morse, Sumeer Thinda, Amar Patel, Allan A Hunter, Ala Moshiri (Davis, USA)
9:20-9:40 Comparison of 577nm pattern and 532 CW single-spot panretinal laser for proliferative diabetic retinopathy. Renato Passos, Mauricio Maia (Sao Paolo, Brazil).
9:40-10:00 Safety and effectiveness of selective retina therapy (SRT) for treatment of diabetic macular edema in Korean patients. Young Jung Roh, Ralf Brinkmann, Young Gun Park (Seoul, South Korea).10:00-10:20
10:00-10:20 Break Refreshments and Sponsor Exhibits (Tahoe Room)
Free Papers II Moderator: Stephen Sinclair (Philadelphia, USA) (Reno Room)
10:20-10:40 Temperature controlled retinal photocoagulation. Ralf Brinkmann, Alex Baade, Kerstin Schlott, Stefan Koinzer, Johann Roider (Luebeck and Kiel, Germany)
10:40-11:00 Computer image guided laser to CNVM feeder vessels. Alexander Gauthier, Matthew Katz, Bert Glaser (Baltimore, USA)
11:00-11:20 Micropulse laser for serous macular detachment due to dome-shaped macula. Edoardo Midena and Elisabetta Pilotto (Padova, Italy)
11:20-11:40 Exploring subthreshold micropulse laser for the treatment of AMD. Azad Mansouri, Khurram Malik, Joshua Steiner, Bert Glaser (Baltimore, USA)
11:40-12:00 Subthreshold micropulse yellow laser for subfoveal neuroretinal detachment due to benign choroidal tumors. Stela Vujosevic, Raffaele Parrozzani, Luisa Frizziero, Ilaria Testi, Edoardo Midena (Padova, Italy)
12:00 – 1:00- Lunch (Tahoe Room) and LIGHT Corporate Sponsor Presentations in Reno Room
Free Papers III Moderator: Bert Glaser (Baltimore, USA) (Reno Room)
1:00-1:20 Sub-lethal micropulse laser photocoagulation induces heat shock protein expression in human RPE cells. Keiji Inagaki, Kishiko Ohkoshi (Tokyo, Japan)
1:20-1:40 Heat shock protein expression following retinal laser therapy. Daniel Palanker, Daniel Lavinsky (Sanford, USA)
1:40-2:00 Effectiveness of low-energy light therapy for the treatment of dry age-related macular degeneration. Results from one-year observation. Andriy Sergienko, Oleksandr Pekaryk, Natalia Dzuba (Kiev, Ukraine)
2:00-2:20 Investigating the Arden hypothesis: A pilot investigation of the prevention of dark adaptation as complementary therapy for DR and DME. David Ramsey, Geoffrey Arden (London, UK)
2:20-2:40 Functionally Guided Retinal Protective Therapy as prophylaxis for dry age-Related and inherited retinal degenerations. A pilot study. Jeffrey K Luttrull (Ventura, USA), Benjamin WL Margolis (Santa Clara, USA)
2:40-3:00 LIGHT Clinical Trial Proposals Daniel Palanker (Stanford, USA) and Jeffrey K Luttrull (Ventura, USA)
3:00-3:15: Break Refreshments and Sponsor Exhibits 3:40-4:30 (Tahoe Room)
3:15-4:00 Mini-Symposium on CSR Moderator: Jan Keunen (Radboud, The Netherlands) (Reno Room)
Sublethal treatment strategies for Central Serous Chorioretinopathy. 577nm PASCAL “Endpoint Management” Daniel Lavinsky (Porto Alegre, Brazil) and Daniel Palanker (Stanford, USA); RCT comparing Micropulse Laser vs Half-Fluence PDT Michael J. Koss (Heidelberg, Germany); Low-intensity / High-density Subthreshold Diode Micropulse laser (SDM) Jeffrey K Luttrull (Ventura, USA); The PLACE Trial: Dutch National RTC Comparing Micropulse diode laser to PDT Jan Keunen for the PLACE Study Group (The Netherlands)
4:00-4:30 Nomenclature Committee Report: Recommendations for an Updated Retinal Laser Terminology. Discussion, Vote. Edoardo Midena, Chair (Padova, Italy)
4:30 – 5:30 Adjourn Reception / Executive Committee debrief